Editas Medicine Inc. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2015
2016
2017
2018
Sales/Revenue
1,629.00
6,053.00
13,728.00
31,937
SG&A Expense
36,470.00
102,039.00
130,978.00
142,410
EBIT
35,312.00
-
119,933.00
113,727
Unusual Expense
35,700.00
-
-
-
Non Operating Income/Expense
1,745.00
57.00
587.00
328
Interest Expense
143.00
-
978.00
-
Pretax Income
72,900.00
97,183.00
120,324.00
109,954
Consolidated Net Income
72,900.00
97,183.00
120,324.00
109,954
Net Income
72,900.00
97,183.00
120,324.00
109,954
Net Income After Extraordinaries
72,900.00
97,183.00
120,324.00
109,954
Net Income Available to Common
73,294.00
97,230.00
120,324.00
109,954
EPS (Basic)
2.00
3.02
2.98
2.33
Basic Shares Outstanding
36,584.50
32,219.70
40,323.60
47,097.70
EPS (Diluted)
2.00
3.02
2.98
2.33
Diluted Shares Outstanding
36,584.50
32,219.70
40,323.60
47,097.70
EBITDA
34,841.00
95,986.00
117,250.00
110,473
Non-Operating Interest Income
-
62.00
-
3,445
Preferred Dividends
394.00
47.00
-
-
About Editas Medicine
View Profile
